SMi Presents the Launch of Cell & Gene Therapy 2018

May 15, 2018

  Date: 10th – 11th October 2018 Workshop: 9th October 2018 Location: Copthorne Tara Hotel, London UK. Website: www.cellandgeneconference.com/ibi   About Cell & Gene Therapy SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October. Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in ...

Read More

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

Jan 4, 2018

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due to the potential immunogenicity of these therapeutics, remains a significant challenge to the successful development of biotherapeutics. In their paper, Dr Karen Hill and Dr Gary Bembridge of Abzena discuss the impact of immunogenicity and approaches that can be taken in pre-clinical development to reduce the effect on product success and patient experience. ...

Read More